Once daily glycopyrronium for the treatment of COPD: pooled analysis of the GLOW1 and GLOW2 studies
暂无分享,去创建一个
E. Kerwin | P. D’Andrea | A. D’Urzo | T. Overend | P. Goyal | Hungta Chen | H. Chen
[1] Dave Singh,et al. Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial , 2012, International journal of chronic obstructive pulmonary disease.
[2] E. Kerwin,et al. Efficacy and safety of NVA237 versus placebo and tiotropium in patients with COPD: the GLOW2 study , 2012, European Respiratory Journal.
[3] K. Hirata,et al. Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial , 2011, Respiratory research.
[4] K. Rabe,et al. Tiotropium versus salmeterol for the prevention of exacerbations of COPD. , 2011, The New England journal of medicine.
[5] M Cazzola,et al. Symptom variability in patients with severe COPD: a pan-European cross-sectional study , 2010, European Respiratory Journal.
[6] M. Partridge,et al. Patient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet survey , 2009, Current medical research and opinion.
[7] D. O’Donnell,et al. The major limitation to exercise performance in COPD is dynamic hyperinflation. , 2008, Journal of applied physiology.
[8] Russell Mardon,et al. Spirometry utilization for COPD: how do we measure up? , 2007, Chest.
[9] P. Jones,et al. Measuring the effects of COPD on the patient. , 2005, Respiratory medicine.
[10] D. Niewoehner,et al. Prevention of Exacerbations of Chronic Obstructive Pulmonary Disease with Tiotropium, a Once-Daily Inhaled Anticholinergic Bronchodilator , 2005, Annals of Internal Medicine.
[11] J. Donohue. Minimal Clinically Important Differences in COPD Lung Function , 2005, COPD.
[12] R. Buhl,et al. Newly Diagnosed Chronic Obstructive Pulmonary Disease , 2003, Respiration.
[13] D. Mahler,et al. Minimal important difference of the transition dyspnoea index in a multinational clinical trial , 2003, European Respiratory Journal.
[14] T. Seemungal,et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease , 2002, Thorax.
[15] R. Zuwallack,et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease , 2002, European Respiratory Journal.
[16] D. D. Briggs,et al. The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study Group. , 2000, Chest.